BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 6401396)

  • 41. The impact of obesity on hormonal parameters in hirsute and nonhirsute women.
    Bernasconi D; Del Monte P; Meozzi M; Randazzo M; Marugo A; Badaracco B; Marugo M
    Metabolism; 1996 Jan; 45(1):72-5. PubMed ID: 8544780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism.
    Prezelj J; Kocijancic A; Andolsek L
    Gynecol Endocrinol; 1989 Dec; 3(4):281-8. PubMed ID: 2516705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of endogenous progesterone on serum levels of 5 alpha-reduced androgens in hirsute women.
    Dewis P; Newman M; Anderson DC
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):383-92. PubMed ID: 6542470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Probable role of obesity on the adrenal response to acute stimulation with adrenocorticotrophic hormone in eumenorrheic and hirsute, non-eumenorrheic women].
    Villa S; Schutz I; Mainini E; Mazzi C; Mazzi C
    Minerva Endocrinol; 1993 Mar; 18(1):13-9. PubMed ID: 8232117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is 3 alpha-androstanediol a marker of peripheral hirsutism?
    Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone mass in hirsute women with androgen excess.
    Dixon JE; Rodin A; Murby B; Chapman MG; Fogelman I
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):271-7. PubMed ID: 2591056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between urinary 17-ketosteroids and serum androgens in hirsute patients.
    Maroulis GB; Manlimos FS; Abraham GE
    Obstet Gynecol; 1977 Apr; 49(4):454-8. PubMed ID: 140340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
    Adams J; Polson DW; Franks S
    Br Med J (Clin Res Ed); 1986 Aug; 293(6543):355-9. PubMed ID: 3089520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal and clinical effects of ketoconazole in hirsute women.
    Martikainen H; Heikkinen J; Ruokonen A; Kauppila A
    J Clin Endocrinol Metab; 1988 May; 66(5):987-91. PubMed ID: 2966183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic evaluation of hirsutism in women by selective bilateral adrenal and ovarian venous catheterization.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Fertil Steril; 1978 Sep; 30(3):283-8. PubMed ID: 710599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral arterial and venous concentrations of various androgens in patients with and without hirsutism.
    Chang RJ; Abraham GE
    Obstet Gynecol; 1975 Nov; 46(5):549-50. PubMed ID: 127957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic evaluation of hirsutism in women.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-dose ketoconazole treatment in hirsute women.
    Sonino N; Scaroni C; Biason A; Boscaro M; Mantero F
    J Endocrinol Invest; 1990 Jan; 13(1):35-40. PubMed ID: 2138647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid profiles in women with hirsutism and polycystic ovaries.
    Senöz S; Ozaksit G; Turhan NO; Gülekli B; Gökmen O
    Gynecol Endocrinol; 1994 Mar; 8(1):33-7. PubMed ID: 8059615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome.
    Guzel AI; Kuyumcuoğlu U; Celik Y
    Arch Gynecol Obstet; 2012 Mar; 285(3):767-70. PubMed ID: 21909749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity affects circulating estradiol levels of premenopausal hirsute women receiving leuprolide acetate depot.
    Dumesic DA; Matteri RL
    Int J Fertil Menopausal Stud; 1993; 38(3):139-46. PubMed ID: 8348161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral, ovarian, and adrenal vein steroids in hirsute women: acute effects of human chorionic gonadotropin and adrenocorticotrophic hormone.
    Parker CR; Bruneteau DW; Greenblatt RB; Mahesh VB
    Fertil Steril; 1975 Sep; 26(9):877-88. PubMed ID: 126875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.